Ivan Kairatov, a renowned expert in biopharma, is at the forefront of innovation in the biotechnology and biomanufacturing industry. With extensive experience in research and development, he has played a pivotal role in advancing sustainable solutions within the field. Today, Ivan shares insights
The cell and gene therapy (CGT) sector stands on the precipice of revolutionary change, reminiscent of the fast food industry’s notable standardization achievements. This provocative comparison emerged during a recent discussion at BPI Europe in Hamburg, where industry leaders delved into the
Ecolab Life Sciences has unveiled a state-of-the-art bioprocessing applications laboratory in King of Prussia, Pennsylvania, setting the stage for significant advances in pharmaceutical innovation. This laboratory is specifically designed to offer technical support and process development services
Ecolab Life Sciences has introduced a groundbreaking Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania, setting new standards in supporting biopharmaceutical firms with molecule purification. Nestled strategically near key pharmaceutical hubs, these facilities are designed to
In the pharmaceutical landscape, Novartis has emerged as a trailblazer with its continuous manufacturing efforts, particularly through its BioFuture site in Schaftenau, Austria. This strategic initiative, highlighted at the BioProcess International Europe event by senior process expert Katharina
The Advanced Biofuels and Bioproducts Process Development Unit (ABPDU) stands as a formidable force reshaping the U.S. biomanufacturing sector amid the demand for sustainable and efficient biotechnological solutions. Since its inception in 2009 under the U.S. Department of Energy's Bioenergy
